Table 1_Clinicopathological features and survival outcomes of HPV-independent versus HPV-a

Dan Wu's systematic review and meta-analysis compares HPV-independent and HPV-associated cervical adenocarcinoma. The dataset includes pooled hazard ratios and odds ratios for survival outcomes and clinical features, derived from studies searched up to March 2026. The file is a 14.5 KB DOCX document published under a CC-BY-4.0 license.

Use Cases

• Compare overall survival (OS) and progression-free survival (PFS) between HPV-independent and HPV-associated adenocarcinoma based on the pooled hazard ratios.
• Assess risks of distant metastasis, local recurrence, and lymphovascular invasion based on the reported odds ratios.
• Inform clinical risk stratification and management strategies based on the distinct clinical behavior described for HPV-independent disease.

Strengths

• Includes specific pooled effect sizes, such as a hazard ratio of 3.37 for overall survival and an odds ratio of -3.00 for lymphovascular invasion.
• Follows PRISMA 2020 guidelines for systematic review and meta-analysis methodology.
• Has a registered protocol (PROSPERO CRD420261348146).

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• The dataset is very small (14.5 KB), suggesting it contains summary results rather than raw patient-level data.

Provenance

Source

figshare

Collection Method

Systematic review and meta-analysis of comparative studies from PubMed, Web of Science, Scopus, Embase, and Cochrane Library.

Time Range

Studies from database inception to 01 March 2026.

Freshness

Last updated 2026-05-08 05:54:02; freshness should be verified.

Geography

null